(Q42635318)

English

Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk

scientific article published on September 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

0 references

author name string

Abdu TA

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Elhadd TA

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Buch H

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Barton D

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Neary R

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Clayton RN

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

387-393

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Cardiovascular disease and risk factors in adults with hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Increased cerebrovascular mortality in patients with hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Endothelial dysfunction in hypopituitary adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

HDL-cholesterol reductions associated with adult growth hormone replacement.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Endothelial dysfunction: cause of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02109.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2004.02109.X

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42635318&oldid=2151482810"